FindTrial
Sign In

The effect of dexmedetomidine for maternal sedation and fetal immobilization during fetoscopic surgery

The effect of dexmedetomidine for maternal sedation and fetal immobilization during fetoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021124
Enrollment
Unknown
Registered
2019-01-29
Start date
2019-02-18
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetoscopic surgery

Interventions

the Remifentanil group:Remifentanil 0.1 ug/kg.min intravenously pump in
the Dexemetomidine group:Dexemetomidine 0.01 ug/kg.min pump in intravenously

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Healthy women in the second trimester of pregnancy (gestational age, 16-25 weeks) carrying a multiple pregnancy and scheduled to either fetoscopic laser coagulation or cord occlusion under spinal or epidural anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patient refusal; 2. Patients who are not suitable for spinal or epidural anesthesia; 3. Patients who are allergic to Dexemetomidine.

Design outcomes

Primary

MeasureTime frame
sedative score;—

Secondary

MeasureTime frame
Vital signs of the mother;fetal heart rate;fetal movement score;—

Countries

China

Contacts

Public ContactPing Zhao

Shengjing Hospital of China Medical University

zhaoping_sj@icloud.com+86 18940258971

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026